Financial Contrast: Cardinal Health (CAH) & Prestige Brand Holdings (PBH)
Cardinal Health (NYSE: CAH) and Prestige Brand Holdings (NYSE:PBH) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.
Volatility and Risk
Cardinal Health has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Prestige Brand Holdings has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.
Valuation and Earnings
This table compares Cardinal Health and Prestige Brand Holdings’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Cardinal Health||$129.98 billion||0.16||$3.07 billion||$4.04||16.46|
|Prestige Brand Holdings||$929.06 million||2.91||$317.46 million||$2.03||25.12|
Cardinal Health has higher revenue and earnings than Prestige Brand Holdings. Cardinal Health is trading at a lower price-to-earnings ratio than Prestige Brand Holdings, indicating that it is currently the more affordable of the two stocks.
This table compares Cardinal Health and Prestige Brand Holdings’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Prestige Brand Holdings||11.70%||16.06%||3.89%|
This is a breakdown of current ratings for Cardinal Health and Prestige Brand Holdings, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Prestige Brand Holdings||0||1||5||0||2.83|
Cardinal Health currently has a consensus price target of $81.09, suggesting a potential upside of 21.96%. Prestige Brand Holdings has a consensus price target of $66.00, suggesting a potential upside of 29.41%. Given Prestige Brand Holdings’ stronger consensus rating and higher probable upside, analysts clearly believe Prestige Brand Holdings is more favorable than Cardinal Health.
Cardinal Health pays an annual dividend of $1.85 per share and has a dividend yield of 2.8%. Prestige Brand Holdings does not pay a dividend. Cardinal Health pays out 45.8% of its earnings in the form of a dividend. Prestige Brand Holdings has increased its dividend for 12 consecutive years.
Insider & Institutional Ownership
87.7% of Cardinal Health shares are owned by institutional investors. Comparatively, 98.6% of Prestige Brand Holdings shares are owned by institutional investors. 0.9% of Cardinal Health shares are owned by company insiders. Comparatively, 1.0% of Prestige Brand Holdings shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Prestige Brand Holdings beats Cardinal Health on 11 of the 17 factors compared between the two stocks.
Cardinal Health Company Profile
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Prestige Brand Holdings Company Profile
Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products. The Company operates through three segments: North American Over-the-Counter (OTC) Healthcare; International Over-the-Counter Healthcare, and Household Cleaning. Its portfolio of OTC healthcare products includes core brands, such as DenTek specialty oral care products, Monistat women’s health products, Nix lice treatment, Chloraseptic sore throat treatments, Clear Eyes eye care products, Compound W wart treatments, The Doctor’s NightGuard dental protector, Little Remedies pediatric over-the-counter products, Efferdent denture care products, Luden’s throat drops, Dramamine motion sickness treatment, BC and Goody’s pain relievers, Beano gas prevention, Debrox earwax remover, and Gaviscon antacid. The Company’s portfolio of Household Cleaning brands includes the Chore Boy, Comet and Spic and Span brands.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.